Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.58 - $1.47 $112,060 - $284,015
-193,208 Reduced 9.27%
1,890,425 $1.13 Million
Q2 2023

Aug 10, 2023

BUY
$1.11 - $1.74 $859,484 - $1.35 Million
774,310 Added 59.14%
2,083,633 $2.71 Million
Q1 2023

May 11, 2023

BUY
$1.66 - $3.67 $1.81 Million - $4 Million
1,089,804 Added 496.45%
1,309,323 $2.3 Million
Q4 2022

Feb 13, 2023

SELL
$2.77 - $5.07 $368,994 - $675,379
-133,211 Reduced 37.77%
219,519 $689,000
Q3 2022

Nov 10, 2022

BUY
$4.27 - $6.39 $167,759 - $251,050
39,288 Added 12.53%
352,730 $1.73 Million
Q2 2022

Aug 19, 2022

BUY
$3.28 - $6.21 $1.03 Million - $1.95 Million
313,442 New
313,442 $1.3 Million
Q1 2022

May 13, 2022

SELL
$5.23 - $7.82 $380,822 - $569,413
-72,815 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$7.29 - $10.97 $72,440 - $109,008
9,937 Added 15.8%
72,815 $546,000
Q3 2021

Nov 15, 2021

SELL
$9.01 - $12.01 $1,018 - $1,357
-113 Reduced 0.18%
62,878 $567,000
Q2 2021

Aug 16, 2021

BUY
$10.17 - $12.64 $640,618 - $796,206
62,991 New
62,991 $754,000
Q1 2021

May 17, 2021

SELL
$10.88 - $17.05 $224,247 - $351,417
-20,611 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$9.23 - $18.18 $277,352 - $546,290
-30,049 Reduced 59.32%
20,611 $322,000
Q3 2020

Nov 16, 2020

BUY
$9.38 - $12.48 $475,190 - $632,236
50,660 New
50,660 $479,000
Q1 2020

May 15, 2020

SELL
$5.05 - $8.85 $50,696 - $88,845
-10,039 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$8.03 - $11.7 $51,640 - $75,242
-6,431 Reduced 39.05%
10,039 $84,000
Q3 2019

Nov 14, 2019

BUY
$9.05 - $12.22 $49,503 - $66,843
5,470 Added 49.73%
16,470 $149,000
Q2 2019

Aug 14, 2019

BUY
$8.75 - $13.03 $96,250 - $143,330
11,000 New
11,000 $118,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.